Quantamental Technologies’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,630
Closed -$342K 392
2023
Q2
$342K Sell
3,630
-4,962
-58% -$431K 0.14% 247
2023
Q1
$711K Sell
8,592
-10,285
-54% -$808K 0.38% 69
2022
Q4
$1.41M Buy
18,877
+1,782
+10% +$137K 0.64% 17
2022
Q3
$1.41M Buy
+17,095
New +$1.64M 0.55% 26
2022
Q2
Sell
-3,346
Closed -$394K 453
2022
Q1
$394K Sell
3,346
-6,671
-67% -$748K 0.23% 174
2021
Q4
$1.3M Buy
+10,017
New +$1.17M 0.66% 23

Other funds holding EW

Quantamental Technologies's EW Position: Q3 2023 in Review

Quantamental Technologies sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 3,630 shares — an estimated $342K sold.

Quantamental Technologies first reported a position in EW in Q4 2021 and held it in 6 quarters. The position peaked at $1.41M in Q3 2022. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Quantamental Technologies reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 3,630 Edwards Lifesciences shares in Q3 2023, an estimated $342K.
  • Quantamental Technologies first reported a position in Edwards Lifesciences in Q4 2021 and held it in 6 quarters.
  • Quantamental Technologies's Edwards Lifesciences position peaked at $1.41M in Q3 2022.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.